Pelthos Therapeutics Inc.
General ticker "PTHS" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $19.7M (TTM average)
Pelthos Therapeutics Inc. follows the US Stock Market performance with the rate: 26.5%.
Estimated limits based on current volatility of 7.5%: low 21.42$, high 24.88$
Short-term PTHS quotes
Long-term PTHS plot
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $16.80MM |
| Operating Expenses | $6.86MM | $7.57MM | $49.23MM |
| Operating Income | $-6.86MM | $-7.57MM | $-32.43MM |
| Non-Operating Income | $-0.52MM | $-0.38MM | $-18.28MM |
| Interest Expense | $0.52MM | $0.79MM | $3.01MM |
| R&D Expense | $2.58MM | $1.18MM | $1.23MM |
| Income(Loss) | $-7.38MM | $-7.96MM | $-50.71MM |
| Taxes | $0.00MM | $0.00MM | $-7.39MM |
| Profit(Loss)* | $-7.38MM | $-7.96MM | $-43.32MM |
| Stockholders Equity | $-6.44MM | $-2.71MM | $38.88MM |
| Inventory | $0.00MM | $0.00MM | $23.57MM |
| Assets | $0.10MM | $1.37MM | $130.40MM |
| Operating Cash Flow | $-0.98MM | $-5.79MM | $-22.59MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.10MM |
| Investing Cash Flow | $0.00MM | $0.00MM | $-5.24MM |
| Financing Cash Flow | $1.02MM | $6.21MM | $45.34MM |
| Earnings Per Share** | $-12.80 | $-13.54 | $-23.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.